BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15859012)

  • 1. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
    Shimizu H; Kumabe T; Tominaga T; Kayama T; Hara K; Ono Y; Sato K; Arai N; Fujiwara S; Yoshimoto T
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):737-47. PubMed ID: 8730195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
    Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
    Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
    Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
    Fan G; Sun B; Wu Z; Guo Q; Guo Y
    Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo proton magnetic resonance spectroscopy of brain tumors.
    Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
    Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.